Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00364689 · ClinicalTrials.gov registry record · Phase 3
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
A Phase 3 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT00364689 is a Phase 3 study that was terminated before completion, run by University of Miami. The registered enrollment target is 13 participants.
The verdict
NCT00364689, a Phase 3 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of three different treatments for hepatic encephalopathy.
Interventions
- OTHER Placebo
- DRUG Rifaximin
- DRUG Lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00364689
The ClinicalTrials.gov registry entry for NCT00364689 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00364689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00364689 about?
NCT00364689 is a clinical study titled "RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial". The purpose of this study is to compare the effectiveness of three different treatments for hepatic encephalopathy.
What is the current status of trial NCT00364689?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2006-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00364689?
The interventions under investigation include: Placebo (OTHER), Rifaximin (DRUG), Lactulose (DRUG).
Who is sponsoring clinical trial NCT00364689?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.